Citation Impact
Citing Papers
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
Expansion and Function of CD8+ T Cells Expressing Ly49 Inhibitory Receptors Specific for MHC Class I Molecules
2004 StandoutNobel
Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future
2004
Formation and Function of the Myofibroblast during Tissue Repair
2007 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Imaging in the era of molecular oncology
2008 StandoutNature
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Inflammation in Wound Repair: Molecular and Cellular Mechanisms
2007 Standout
Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors
2005
The Role of Natural Killer T Cells in Cancer—A Phenotypical and Functional Approach
2018
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC
2006
Putting tumours in context
2001 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Extracellular matrix structure
2015 Standout
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
Mechanisms of Hepatic Fibrogenesis
2008 Standout
NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death
2018
Cytokine patterns in patients with cancer: a systematic review
2013 Standout
The regulation of lymphocyte activation by inhibitory receptors
2004
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Microenvironmental regulation of metastasis
2008 Standout
HLA-G Molecules: from Maternal–Fetal Tolerance to Tissue Acceptance
2003
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
2006
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
2003 Standout
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles
2006
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Breast cancer metastasis: markers and models
2005 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
2014
NK CELL RECOGNITION
2004 Standout
Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells
2007 Standout
Global gene expression of cells attached to a tissue engineering scaffold
2004 StandoutNobel
Innate Vα14+ natural killer T cells mature dendritic cells, leading to strong adaptive immunity
2007 StandoutNobel
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
NK Cells and Cancer
2007
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
The extracellular matrix at a glance
2010 Standout
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens
2015
Interferon-α as an immunotherapeutic protein
2002
Gout
2021 Standout
Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response
2006
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
2008 Standout
Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity
2015
Works of Asma Gati being referenced
Tumor escape from killing: Role of killer inhibitory receptors and acquisition of tumor resistance to cell death
2002
Comparison of circulating and intratumoral regulatory T cells in patients with renal cell carcinoma
2015
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients
2006
Tumor cells regulate the lytic activity of tumor-specific cytotoxic t lymphocytes by modulating the inhibitory natural killer receptor function.
2001
Spontaneous CD8 T Cell Responses against the Melanocyte Differentiation Antigen RAB38/NY-MEL-1 in Melanoma Patients
2006
Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction
2002
Ex Vivo Characterization of Allo-MHC-Restricted T Cells Specific for a Single MHC-Peptide Complex
2006
CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.
2003